Quest Settles Ravgen Prenatal Test Patent Suit On Eve Of Trial
Quest Diagnostics Inc. reached a deal with Ravgen Inc. resolving the small biotech business' claims that Quest infringed its prenatal genetic test patents ahead of a trial set to kick off...To view the full article, register now.
Already a subscriber? Click here to view full article